Tag: Melanoma patient outcomes with targeted therapy
Long-Term Survival Rates for Advanced Melanoma Patients with Combination Drug Therapy
More than half of people diagnosed with advanced melanoma now survive for at least 10 years when they receive a double hit of immunotherapy drugs, a trial has found. The combined treatment has transformed...